rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2002-5-17
|
pubmed:abstractText |
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are managed with increased doses or frequency of the patient's existing bronchodilator therapy. The use of formoterol in the treatment of mild acute exacerbations of COPD has been suggested; however, a comparison of cumulative doses of formoterol with salbutamol, the gold standard bronchodilator agent for this pathologic condition, is still lacking.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0149-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
595-604
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12017404-Administration, Inhalation,
pubmed-meshheading:12017404-Aged,
pubmed-meshheading:12017404-Albuterol,
pubmed-meshheading:12017404-Bronchodilator Agents,
pubmed-meshheading:12017404-Cross-Over Studies,
pubmed-meshheading:12017404-Dose-Response Relationship, Drug,
pubmed-meshheading:12017404-Ethanolamines,
pubmed-meshheading:12017404-Female,
pubmed-meshheading:12017404-Forced Expiratory Volume,
pubmed-meshheading:12017404-Humans,
pubmed-meshheading:12017404-Male,
pubmed-meshheading:12017404-Middle Aged,
pubmed-meshheading:12017404-Nebulizers and Vaporizers,
pubmed-meshheading:12017404-Oximetry,
pubmed-meshheading:12017404-Oxygen Consumption,
pubmed-meshheading:12017404-Powders,
pubmed-meshheading:12017404-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:12017404-Single-Blind Method,
pubmed-meshheading:12017404-Smoking,
pubmed-meshheading:12017404-Vital Capacity
|
pubmed:year |
2002
|
pubmed:articleTitle |
Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
|
pubmed:affiliation |
Department of Respiratory Medicine, A. Cardarelli Hospital, Naples, Italy. mcazzola@qubisoft.it
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|